Top Stock Signal: PALI
Report Date: 01-29-2024
Symbol: PALI - Palisade Bio, Inc.
Sector: Healthcare
Industry: Biotechnology
Top Stock Signal: PALI
Palisade Bio, Inc. (PALI)
20271 Goldenrod Ln Ste 2024
Germantown, MARYLAND 92008
Phone: 13013664841
Website: https://www.palisadebio.com
CEO: Mr. Richard Daly
NASDAQ, Nasdaq Global Select
Palisade Bio, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress, such as results from reduced blood flow to the intestine, infections, and surgery. The company was founded in 2005 and is based in Carlsbad, California.